Overview
ArcHouse provides an AI-native operations platform that automates the pre-admission process for hospice and home-based care providers. It uses a unified intake inbox, automatic medical-record retrieval from health information networks, AI-driven summaries of clinical documents, and automated insurance and Medicare eligibility checks, consent forms, and e-signatures, with Radar monitoring patient status, and it works as an extension to existing EMR systems. Unlike typical tools, it focuses on end-to-end pre-admission workflow automation rather than replacing EMRs or offering a standalone referral feature. Its goal is to cut pre-admission time from days to hours and grow toward a full operating system for hospice care with scalable B2B pricing.
Work here?Claim your company
Simplify's take
What believers are saying
- Struck Capital co-led ArcHouse's $2.7 million Seed round on November 24, 2025.
- ArcHouse's 2026 customer stories show 5% conversion lift and two hours saved.
- The company is hiring product marketing and operations roles, signaling active expansion in 2026.
What critics are saying
- WellSky, Netsmart myUnity, Axxess, and Homecare Homebase already own provider workflows.
- Hospice buyers face EHR sprawl; ArcHouse must prove safe integrations across every site.
- If referrals stay manual elsewhere, ArcHouse becomes a niche workflow tool, not an operating system.
What makes ArcHouse unique
- ArcHouse automates hospice pre-admissions end-to-end, not just referral tracking.
- Its AI gathers records, drafts consents, and verifies Medicare eligibility in one workflow.
- Redwood Hospice reported 15–30 minute responses after adopting ArcHouse in 2026.
Help us improve and share your feedback! Did you find this helpful?